On November 7, Accenture, Takeda Pharmaceutical Company Limited, and AWS signed an innovative strategic cooperation agreement at the Medical Devices and Healthcare Products Area of the China International Import Expo, and jointly launched the "TakedaSpark+" 2022 Takeda China Innovation Challenge.
The three parties will leverage their respective expertise in healthcare, professional consulting, and technology incubation to jointly identify projects with genuine implementation value in the fields of "digital therapeutics," "early screening and diagnostics," and "smart services." Throughout the incubation process, the three parties will adhere to the core strategy of TakedaSpark+ Innovation Incubation Platform: "collaboration, win-win, and implementation," exploring the establishment of an industry cooperation model that spans the full cycle from incubation to commercialization in the digital healthcare sector.